In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 63675-74-1, name is 6-Methoxy-2-(4-methoxyphenyl)-1-benzothiophene, introducing its new discovery. name: 6-Methoxy-2-(4-methoxyphenyl)-1-benzothiophene
BENZOTHIOPHENE DERIVATIVES AND COMPOSITIONS THEREOF AS SELECTIVE ESTROGEN RECEPTOR DEGRADERS
The present invention relates to compounds of formula I: in which n, m, X, Y 1, R1, R2, R3, R4 and R5 are defined in the Summary of the Invention; capable of being both potent antagonists and degraders of estrogen receptors. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds and compositions in the management of diseases or disorders associated with aberrant estrogen receptor activity.
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 63675-74-1, and how the biochemistry of the body works.name: 6-Methoxy-2-(4-methoxyphenyl)-1-benzothiophene
Reference£º
Benzothiophene – Wikipedia,
Benzothiophene | C8H6S – PubChem